Change Language
English - Change Language
Recent Updates
  • In the past few years, there has been a significant surge in the demand for recombinant proteins and cellular systems for biomedical research, diagnostics and different therapies. In order to support the large- scale production and manufacturing of such cell- based products, there is an imperative need for the efficient development of high- quality stable cell lines. In fact, 60-70% of manufacturing processes of available biologics require live mammalian systems. A cell line refers to a defined population of cells that originates from a single common ancestor cell and have the ability to retain stable phenotypes and functions. In general, once the primary culture is sub-cultured, it becomes a cell line.

    To request a sample copy / brochure of this report, please visit : https://www.rootsanalysis.com/reports/cell-line-development-and-characterization-services/request-sample.html
    In the past few years, there has been a significant surge in the demand for recombinant proteins and cellular systems for biomedical research, diagnostics and different therapies. In order to support the large- scale production and manufacturing of such cell- based products, there is an imperative need for the efficient development of high- quality stable cell lines. In fact, 60-70% of manufacturing processes of available biologics require live mammalian systems. A cell line refers to a defined population of cells that originates from a single common ancestor cell and have the ability to retain stable phenotypes and functions. In general, once the primary culture is sub-cultured, it becomes a cell line. To request a sample copy / brochure of this report, please visit : https://www.rootsanalysis.com/reports/cell-line-development-and-characterization-services/request-sample.html
    Request Sample - Cell Line Development and Characerization Services Market | Industry Analysis | Market Size | 2030
    The Cell Line Development and Characterization Services Market, 2020-2030 report features an extensive study on the current market landscape...
    0 Comments 0 Shares
  • Roots Analysis has announced the addition of “Antibody Discovery: Services and Platforms Market (3rd Edition), 2020-2030” report to its list of offerings.

    The development of such biologics is inherently complex, and many drug developers are now seeking to optimize R&D efficiency and affiliated costs. As a result, innovator companies are outsourcing most of their discovery-stage operations to specialty contract research organizations (CROs), which offer a plethora of advanced technologies to cater to the evolving needs. It is also worth highlighting that stakeholders engaged in this domain are actively undertaking initiatives to develop interventions for SARS-CoV-2 virus.

    To order this 450+ page report, which features 120+ figures and 140+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/antibody-discovery-services-and-platforms/213.html
    Roots Analysis has announced the addition of “Antibody Discovery: Services and Platforms Market (3rd Edition), 2020-2030” report to its list of offerings. The development of such biologics is inherently complex, and many drug developers are now seeking to optimize R&D efficiency and affiliated costs. As a result, innovator companies are outsourcing most of their discovery-stage operations to specialty contract research organizations (CROs), which offer a plethora of advanced technologies to cater to the evolving needs. It is also worth highlighting that stakeholders engaged in this domain are actively undertaking initiatives to develop interventions for SARS-CoV-2 virus. To order this 450+ page report, which features 120+ figures and 140+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/antibody-discovery-services-and-platforms/213.html
    WWW.ROOTSANALYSIS.COM
    Antibody Discovery: Services and Platforms Market (4rd Edition) | Industry Analysis | Market Size | 2030
    We anticipate the antibody discovery services and platforms market to grow at an annualized rate of over 23% in the coming decade; the opportunity is likely to be well-distributed across geographies
    0 Comments 0 Shares
  • Roots Analysis has announced the addition of “Handheld Imaging Devices Market, 2020-2030” report to its list of offerings.

    According to industry experts, handheld imaging devices are being adopted at a faster pace by different end-users owing to their higher efficiency and wider applicability. Further, these devices have proven to be useful in quarantining patients demonstrating symptoms of pleural wall thickening and lung congestion, a characteristic of pneumonia, as well as observed in patients suffering from the novel coronavirus (COVID-19).

    To order this 235+ page report, which features 95+ figures and 110+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/handheld-imaging-devices/319.html
    Roots Analysis has announced the addition of “Handheld Imaging Devices Market, 2020-2030” report to its list of offerings. According to industry experts, handheld imaging devices are being adopted at a faster pace by different end-users owing to their higher efficiency and wider applicability. Further, these devices have proven to be useful in quarantining patients demonstrating symptoms of pleural wall thickening and lung congestion, a characteristic of pneumonia, as well as observed in patients suffering from the novel coronavirus (COVID-19). To order this 235+ page report, which features 95+ figures and 110+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/handheld-imaging-devices/319.html
    WWW.ROOTSANALYSIS.COM
    Handheld Ultrasound Imaging Devices | Industry Analysis | Market Size | 2030
    With enhanced demand for point-of-care imaging solution, the handheld ultrasound imaging devices market is estimated to reach USD 1.2 billion by 2030
    0 Comments 0 Shares

  • Roots Analysis has announced the addition of the “HUMIRA® (Adalimumab) Biosimilars – Pipeline Review and Partnerships” report to its list of offerings.

    Detailed review of the adalimumab biosimilars pipeline and affiliated developer landscape, featuring a list of involved innovator companies and their respective therapy candidates. It includes insights based on the current status of biosimilar candidates, and important developer related details (including headquarters, and type of developer).

    For additional details, please visit
    https://www.rootsanalysis.com/reports/humira-biosimilars-pipeline-review-and-partnerships.html
    Roots Analysis has announced the addition of the “HUMIRA® (Adalimumab) Biosimilars – Pipeline Review and Partnerships” report to its list of offerings. Detailed review of the adalimumab biosimilars pipeline and affiliated developer landscape, featuring a list of involved innovator companies and their respective therapy candidates. It includes insights based on the current status of biosimilar candidates, and important developer related details (including headquarters, and type of developer). For additional details, please visit https://www.rootsanalysis.com/reports/humira-biosimilars-pipeline-review-and-partnerships.html
    WWW.ROOTSANALYSIS.COM
    HUMIRA®1 (Adalimumab) Biosimilars - Pipeline Review and Partnerships
    HUMIRAR (Adalimumab) Biosimilars - Pipeline Review and Partnerships report features an extensive study of the current market landscape and future potential...
    0 Comments 0 Shares
  • Roots Analysis has announced the addition of “Pharmaceutical Secondary Packaging Market” report to its list of offerings.

    The anticipated growth in the therapeutics pipeline is likely to translate into a significant rise in the demand for cost-effective and quality secondary packaging solutions, presenting lucrative opportunities for contract packaging organizations. Driven by the growth of the overall pharmaceutical industry and increasing preference of drug developers for outsourcing certain operations, the secondary packaging providers market is expected to witness a steady increase.

    To order this 210+ page report, which features 130+ figures and 160+ tables, please visit
    https://www.rootsanalysis.com/reports/pharmaceutical-secondary-packaging-market.html
    Roots Analysis has announced the addition of “Pharmaceutical Secondary Packaging Market” report to its list of offerings. The anticipated growth in the therapeutics pipeline is likely to translate into a significant rise in the demand for cost-effective and quality secondary packaging solutions, presenting lucrative opportunities for contract packaging organizations. Driven by the growth of the overall pharmaceutical industry and increasing preference of drug developers for outsourcing certain operations, the secondary packaging providers market is expected to witness a steady increase. To order this 210+ page report, which features 130+ figures and 160+ tables, please visit https://www.rootsanalysis.com/reports/pharmaceutical-secondary-packaging-market.html
    WWW.ROOTSANALYSIS.COM
    Pharmaceutical Secondary Packaging Market | Industry Analysis | Market Size | 2035
    Market research report on Pharmaceutical Secondary Packaging Market; with a focus on current landscape, key players and future growth opportunities
    0 Comments 0 Shares
  • Roots Analysis is pleased to announce the publication of its recent study, titled, “Medical Device CROs Market, 2019-2030.”

    The report features a detailed study on the current landscape of contract service providers focused on regulatory affairs management for medical devices. The study features an in-depth analysis, highlighting the capabilities of the various CROs engaged in this domain, across different regions of the globe. Amongst other elements, the report includes:
     A detailed review of the current Medical Device CRO market landscape of the medical devices regulatory affairs outsourcing market, featuring a list of over 400 CROs engaged in this domain.
    For more information please click on the following link
    https://www.rootsanalysis.com/reports/view_document/med-dev-regulatory/282.html
    Roots Analysis is pleased to announce the publication of its recent study, titled, “Medical Device CROs Market, 2019-2030.” The report features a detailed study on the current landscape of contract service providers focused on regulatory affairs management for medical devices. The study features an in-depth analysis, highlighting the capabilities of the various CROs engaged in this domain, across different regions of the globe. Amongst other elements, the report includes:  A detailed review of the current Medical Device CRO market landscape of the medical devices regulatory affairs outsourcing market, featuring a list of over 400 CROs engaged in this domain. For more information please click on the following link https://www.rootsanalysis.com/reports/view_document/med-dev-regulatory/282.html
    WWW.ROOTSANALYSIS.COM
    Contract Regulatory Affairs Management Market for Medical Devices, 2019-2030-Futuer Forecast | Indsutry Analysis | Market Size | 2030
    Driven by Rapidly growing Demand, the Contract Regulatory Affairs Market for Medical Device is anticipated to grow at an annualized rate of around 7% till 2030
    0 Comments 0 Shares
  • Roots Analysis is pleased to announce the publication of its recent study, titled, “Medical Device CROs Market, 2019-2030.”

    The report features a detailed study on the current landscape of contract service providers focused on regulatory affairs management for medical devices. The study features an in-depth analysis, highlighting the capabilities of the various CROs engaged in this domain, across different regions of the globe. Amongst other elements, the report includes:
     A detailed review of the current Medical Device CRO market landscape of the medical devices regulatory affairs outsourcing market, featuring a list of over 400 CROs engaged in this domain.
    Roots Analysis is pleased to announce the publication of its recent study, titled, “Medical Device CROs Market, 2019-2030.” The report features a detailed study on the current landscape of contract service providers focused on regulatory affairs management for medical devices. The study features an in-depth analysis, highlighting the capabilities of the various CROs engaged in this domain, across different regions of the globe. Amongst other elements, the report includes:  A detailed review of the current Medical Device CRO market landscape of the medical devices regulatory affairs outsourcing market, featuring a list of over 400 CROs engaged in this domain.
    0 Comments 0 Shares
  • Roots Analysis has announced the addition of “Biopreservation Media Providers Market” report to its list of offerings.

    Several companies across the globe are now offering a variety of biopreservation media that assist the transport and storage of cells, tissues and organs, across various preservation conditions. It is worth highlighting that such pre-formulated media ensure product quality, efficacy, viability and post preservation high cell recovery. Given the inclination of industry stakeholders towards the field of cellular therapy, regenerative medicine and biobanking, the demand for biopreservation media intended for clinical purposes is anticipated to rise in the coming years.

    To order this 230+ page report, which features 90+ figures and 100+ tables, please visit https://www.rootsanalysis.com/reports/biopreservation-media-providers-market.html
    Roots Analysis has announced the addition of “Biopreservation Media Providers Market” report to its list of offerings. Several companies across the globe are now offering a variety of biopreservation media that assist the transport and storage of cells, tissues and organs, across various preservation conditions. It is worth highlighting that such pre-formulated media ensure product quality, efficacy, viability and post preservation high cell recovery. Given the inclination of industry stakeholders towards the field of cellular therapy, regenerative medicine and biobanking, the demand for biopreservation media intended for clinical purposes is anticipated to rise in the coming years. To order this 230+ page report, which features 90+ figures and 100+ tables, please visit https://www.rootsanalysis.com/reports/biopreservation-media-providers-market.html
    WWW.ROOTSANALYSIS.COM
    Biopreservation Media Providers Market | Market Size | Industry Analysis | 2035
    Driven by the rising approval of thermo-sensitive products, the market for biopreservation media is poised to grow at an annualized rate of over 15%, till 2035...
    0 Comments 0 Shares
  • The “Teleradiology Services Market, report features an extensive study of the current landscape, offering an informed opinion on the likely adoption of teleradiology solutions in the diagnostic imaging industry, till 2030. The report features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain.
    To request a sample report: https://www.rootsanalysis.com/reports/teraradiology-services-market/request-sample.html

    The “Teleradiology Services Market, report features an extensive study of the current landscape, offering an informed opinion on the likely adoption of teleradiology solutions in the diagnostic imaging industry, till 2030. The report features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. To request a sample report: https://www.rootsanalysis.com/reports/teraradiology-services-market/request-sample.html
    Request Sample - Teleradiology Services Market | Remote Diagnosis | Online Health | Telemedicine | Medical Imaging | Market Size | 2030
    Driven by rising demand for remote patient diagnosis, the teleradiology services market is anticipated to grow at an annualized rate of about 17%, till 2030...
    0 Comments 0 Shares
  • The Novel Ocular Drug Delivery Devices Market report features an extensive study of the current market landscape and the likely adoption of novel ocular drug delivery devices, over the next decade. The study features a detailed analysis of the key drivers and trends related to this evolving domain.

    According to the World Health Organization (WHO), more than 2.2 billion individuals across the world suffer from some degree of vision impairment caused due to various ophthalmic disorders, such as glaucoma, trachoma, cataract, diabetic retinopathy and wet age-related macular degeneration. Around 50% of the cases are left either unaddressed and / or could have been prevented. It is also worth highlighting that around 1.7 billion individuals worldwide are expected to lose their vision by 2050. Studies suggest that, if administered with the help of topical eye drops, around 95% of the drug is lost due to a number of challenges, such as dilution of product by tears and permeation issues related to cornea. Therefore, drug delivery formulations, such as eye drops and ointments, cannot be considered as an optimal treatment option for vision-threatening diseases.

    To request a sample report: https://www.rootsanalysis.com/reports/novel-ocular-drug-delivery-devices-market/request-sample.html
    The Novel Ocular Drug Delivery Devices Market report features an extensive study of the current market landscape and the likely adoption of novel ocular drug delivery devices, over the next decade. The study features a detailed analysis of the key drivers and trends related to this evolving domain. According to the World Health Organization (WHO), more than 2.2 billion individuals across the world suffer from some degree of vision impairment caused due to various ophthalmic disorders, such as glaucoma, trachoma, cataract, diabetic retinopathy and wet age-related macular degeneration. Around 50% of the cases are left either unaddressed and / or could have been prevented. It is also worth highlighting that around 1.7 billion individuals worldwide are expected to lose their vision by 2050. Studies suggest that, if administered with the help of topical eye drops, around 95% of the drug is lost due to a number of challenges, such as dilution of product by tears and permeation issues related to cornea. Therefore, drug delivery formulations, such as eye drops and ointments, cannot be considered as an optimal treatment option for vision-threatening diseases. To request a sample report: https://www.rootsanalysis.com/reports/novel-ocular-drug-delivery-devices-market/request-sample.html
    Request Sample - Novel Ocular Drug Delivery Devices | Market Size | Industry Analysis | 2030
    Novel Ocular Drug Delivery Devices Market report features an extensive study of the current market landscape and future potential of the...
    0 Comments 0 Shares
More Stories